Related Experiment Videos
Immunological and virological markers determining progression to AIDS
P T Schellekens1, M Koot, M T Roos
1Department of Clinical Viro-Immunology, Central Laboratory of The Netherlands Red Cross Blood Transfusion Service, Amsterdam.
The Netherlands Journal of Medicine
|December 1, 1994
Summary
Human immunodeficiency virus (HIV-1) infection depletes CD4+ T-helper cells. This review discusses additional markers like CD4+ cell decline rate, T-cell reactivity, and HIV phenotype for predicting AIDS progression.
Area of Science:
- Immunology
- Virology
- Clinical Medicine
Background:
- Human immunodeficiency virus (HIV-1) infection causes severe immunodeficiency by depleting CD4+ T-helper cells.
- CD4+ cell count predicts acquired immunodeficiency syndrome (AIDS) progression in asymptomatic individuals.
- Clinical progression varies among individuals with similar CD4+ cell counts, necessitating additional predictive markers.
Purpose of the Study:
- To review additional markers for predicting disease progression in HIV-1 infection.
- To explore the clinical importance of markers beyond CD4+ cell count.
- To gain insight into immunopathological mechanisms of AIDS development.
Main Methods:
- Review of existing literature on HIV-1 progression markers.
- Discussion of CD4+ cell decline rate as a progression marker.
- Analysis of T-cell reactivity and HIV biological phenotype as predictive markers.
Main Results:
- The rate of CD4+ cell decline is a useful independent marker for HIV-1 progression.
- T-cell reactivity provides insights into immune response and disease progression.
- HIV biological phenotype influences the rate of progression to AIDS.
Conclusions:
- Additional markers, including CD4+ cell decline rate, T-cell reactivity, and HIV phenotype, are crucial for predicting HIV-1 progression.
- These markers offer valuable insights into the immunopathology of AIDS.
- Developing accurate predictive markers is of major clinical importance for managing HIV-1 infection.